Cytex Accepted in NIH Commercialization Acceleration Program

Cytex is delighted to be awarded entry to the highly successful Commercialization Acceleration Program offered as a competitive award to recipients of NIH Phase II SBIR or STTR awards.  The program provides training and support for Cytex staff in commercialization activities such as regulatory planning, investment negotiations, and product marketing.